网站大量收购闲置独家精品文档,联系QQ:2885784924

VELOSAVRplatformforship-evacuationanalysis..doc

  1. 1、本文档共17页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
VELOSAVRplatformforship-evacuationanalysis.

Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes??Original Research Article Atherosclerosis, Volume 194, Issue 1, September 2007, Pages 265-271 Helena Tenenbaum, Solomon Behar, Valentina Boyko, Yehuda Adler, Enrique Z. Fisman, David Tanne, Mordechai Lapidot, Ehud Schwammenthal, Micha Feinberg, Zipora Matas, Michael Motro, Alexander Tenenbaum ?Close preview??|?? Related articles??|??Related reference work articles???? AbstractAbstract | Figures/TablesFigures/Tables | ReferencesReferences Abstract Objective Development of insulin resistance (IR) and the progressive failure of the pancreatic beta-cell function (BCF) may be important in the pathogenesis of type 2 diabetes. Influence of peroxisome proliferator-activated receptors ligand bezafibrate on BCF and IR in patients with diabetes is unknown. The present study was aimed to investigate the long-term effect of bezafibrate on these parameters in diabetic patients enrolled in the Bezafibrate Infarction Prevention (BIP) Study. Methods Metabolic and inflammatory parameters were analyzed from stored frozen plasma samples obtained from 351 diabetic patients (168 treated by bezafibrate and 183 by placebo) who completed a 2-year of randomized, double-blind, placebo-controlled study period. The homeostatic indexes of BCF (HOMA-BCF) and IR (HOMA-IR) were calculated according to the homeostasis model of assessment. Results Both groups displayed similar baseline characteristics. During follow-up, in the placebo group there was 28% rise of HOMA-IR (p??0.001). In contrast, HOMA-IR in patients in the bezafibrate group did not change (p?=?0.99). The intergroup differences in HOMA-IR percentage changes were in favor of bezafibrate (p?=?0.01). HOMA-BCF values have significantly decreased by 13.9% (p?=?0.04) in patients of placebo group, whereas in patients of bezafibrate group HOMA-BCF was stable during follow-up and its alterations (?2.9%) were non-significant (p?=

文档评论(0)

bhzs + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档